Paxlovid Reduces Risk of COVID Death by 79% in Older Adults: Study

The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients who are ages 65 and older, according to a new study published in The New England Journal of Medicine.

Related Keywords

Israel ,Jerusalem ,Israel General ,Israeli ,Doron Netzer ,Clalit Health Services In Tel Aviv ,New England Journal ,Clalit Health Services ,Tel Aviv ,Paxlovid ,Covid 19 ,Coronavirus ,Oes Paxlovid Work ,Ho Needs Paxlovid ,Covid ,Reatment For Covid Infection ,Ntiviral For Covid ,Axlovid Side Effects ,Axlovid Rebound Covid ,Isk Of Dying From Covid ,New England Journal Of Medicine ,Ew England Journal Of Medicine Study ,Est Treatment For Covid ,Igns Of Covid ,Igns Of Covid Infection ,